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Background: Cancer-related pain continues to be a major healthcare issue worldwide. Despite the availability of
effective analgesic drugs, published guidelines and educational programs for Health Care Professionals (HCPs) the
symptom is still under-diagnosed and its treatment is not appropriate in many patients. The objective of the study
is to evaluate the efficacy of the Pac-IFicO programme in improving the quality of pain management in hospitalised
cancer patients.
Methods/design: This is a before-after cluster phase II study. After the before assessment, the experimental
intervention – the Pac-IFicO programme – will be implemented in ten medicine, oncology and respiratory disease
hospital wards. The same assessment will be repeated after the completion of the intervention. The Pac-IFicO
programme is a complex intervention with multiple components. It includes focus group with ward professionals
for identifying possible local obstacles to optimal pain control, informative material for the patients, an educational
program performed through guides from the wards, and an organisational intervention to the ward. The primary
end-point of the study is the proportion of cancer patients with severe pain. Secondary end-points include opioids
administered in the wards, knowledge in pain management, and quality of pain management. We plan to recruit
about 500 cancer patients. This sample size should be sufficient, after appropriate statistical adjustments for
clustering, to detect an absolute decrease in the primary end-point from 20% to 9%.
Discussion: This trial is aimed at exploring with an experimental approach the efficacy of a new quality
improvement educational intervention.
Trial registration: ClinicalTrials.gov: NCT02035098
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Pain is one of the most common reasons for request-
ing health care service attention. The World Health
Organization (WHO) estimates that 20% of individuals
worldwide have some degree of chronic pain [1,2].
Despite the availability of effective analgesic drugs and
of published guidelines [3-8] as well as of educational pro-
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article, unless otherwise stated.pain [9], chronic pain is still under-diagnosed and its
treatment is not adequate in many patients with both
solid and haematological malignancies, in any stage of
the disease [10,11].
Data from a systematic revision of the literature show
that pain prevalence in cancer patients ranges from 33%
in patients after curative treatment to 59% in patients
on anticancer treatment, up to 64% in patients with
advanced or terminal phase of disease [12].
Pain was undertreated in about 50% of the cancer
patients evaluated in 26 trial by means of the Pain
Management Index (PMI) [13] which evaluates the
congruence between the patient’s reported level of paintral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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Other surveys conducted in Italy and across Europe
[10,14,15] confirmed these data, showing that pain
was experienced in all cancer stages and that it was
inadequately managed in a significant percentage of
patients, both in early and metastatic stages, ranging
between 56% and 82% and it is undertreated in
oncology clinics, pain and palliative care and hospice
canters [16-18].
Since 2010 pain assessment has been required by law
for all patients in all Italian hospitals [19]. Major causes of
undertreated pain in our country include: administration
of analgesic drugs on request versus around the clock,
prolonged use of no steroidal anti-inflammatory drugs
[20], the employment of weak opioids, also for long
periods of time, instead of strong opioids, the use of
low doses of strong opioids [10,15] as well as the use
of strong opioids only in metastatic and advanced
disease stages, in order to avoid physical or psychological
dependence, tolerance or side effects. All these factors
were found to be related to malpractice among Health
Care Professionals (HCPs).
The systematic management of cancer related pain is
not included in the standard educational programs for
clinicians in the Italian schools of medicine, whereas
specific courses are available for nurses, who may also
access a larger number of training courses on pain
assessment and management, compared to clinicians
[21-25]. On the whole, educational programs for health
workers rarely meet the need for an adequate pain
control in the daily practice. This may depend on different
factors, such as : lack of comprehensive training programs
for all the different health professionals involved in
pain assessment and management, pain assessment
carried out by nurses that is rarely followed by an effect-
ive evaluation and prescription by physicians, which
demotivates nurses [9].
As indicated in the international guidelines, the optimal
treatment of pain in cancer patients has recently been
acknowledged as a major goal to guarantee the quality of
care in hospitalized patients.
The availability of an effective protocol to improve the
quality of pain control in hospitalized patients is mandatory
in the daily practice in hospital units.
There is enough evidence supporting the potential
effectiveness of the single issues (concerning the extent
of information to the patients, education of HCPs and
organizational support) of a program for the improvement
of the quality of pain control in hospitalized patients
[26-40]. The implementation and the effectiveness
assessment of new pain educational programs is a
mandatory issue (including education, information
and organizational support) with the aim to improve pain
measurement and control in all stages of oncologicaldiseases. Such programs should have a multidisciplinary
approach, thus involving nurses, physicians, psychologists,
spiritual assistants and social workers, providing all
health professionals with the needed information and
training through a team work combining professional
expertise and cure tailoring, and involving patients,
who must be informed about pain and pain management
and be encouraged to take an active role in their pain
management [5,41].
A group of health professionals from different institutions
developed a complex educational intervention aimed
at improving pain control in hospitalized cancer patients.
The acronym of the programme is Pac-IficO (P for
Protocol, I for Information; F for Education and O
for Organization). The Pac-IficO Programme includes
a number of integrated interventions and is targeted to
hospital wards, with the aim to significantly improve pain
control in cancer patients.
The general aim of this study is assessing the effective-
ness of the Pac-IFicO Programme in improving the quality
of pain management in hospitalised cancer patients.





The primary aim of this trial is to evaluate the effectiveness
of the Pac-IFicO programme in improving the control of
severe pain in cancer patients admitted to general
medicine, oncology and respiratory disease wards of
three Italian regions.
Secondary aims
The secondary aims of this study include the assessment
of:
○ type and quantity of opioids administered in the
wards;
○ knowledge of the ward professionals in pain
management;
○ quality of pain management in cancer patients.
Study design
This is a multicentre uncontrolled before–after cluster
trial performed within hospital wards participating in
the assessment of the Pac-IFicO programme.
The main objective of the Pac-IFicO programme is
improving the quality of pain management in hospitalised
cancer patients. The targets of the intervention are the
professionals working in the hospital ward, but the out-
comes of interest are assessed in clusters of patients from
the hospital wards before and after the implementation of
the Pac-IFicO programme.
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Preliminary phase
○ Identification of the eligible wards
“Before” assessment in the selected wards
○ Before evaluation according to the procedures of
assessment
Implementation of the experimental intervention
in the selected wards
○ Implementation of the PAC-IFicO programme
“After” assessment in the selected wards
○ After evaluation according to the procedures of
assessment
Procedures of the study
Identification of the wards
The three regional coordinators of the study obtained from
local health authorities the list of all hospitals and wards
of the region. For each ward the following information was
collected: denomination and classification, number of beds,
number of ordinary admissions per year with a primary or
secondary diagnosis of tumour (ICD-IX 140-239) and their
average length of stay in ward. An approximation of the
punctual prevalence of the oncological patients was esti-
mated for each ward from the last two information.
The process of identification of the eligible wards
participating to this study is performed according to
the following procedures:
➣ identification of all potential eligible units from
the list of the hospital wards of each region
(criteria 2-6 of the ward-level inclusion criteria);
➣ phone interview with the nurse coordinators on
previous training on pain management received by the
wards (criteria 1 of the ward-level exclusion criteria);
➣ random sampling, for each region, of the first eligible
ward and subsequent evaluation of the consent from
the Hospital management and the head of the ward to
participate in the study. The procedure were repeated
until two eligible units per region were identified.
The procedures and the dimensions of assessment for
each identified ward include three levels:
Ward level
○ Information about the total consumption of opioids
of the ward in the 6 months before and in the 6months after the implementation of the Pac-IFicO
programme were collected from the Hospital
pharmacy.
Staff level
○ For all physicians and nurses of the ward
information about qualification, years of service,
training in pain management were collected.
○ Knowledge of the ward professionals in pain
management were assessed before and after the
implementation of the intervention by
administering the Italian version of the Pain
Attitudes and Knowledge Scale (PAK) [24,42];
Patient level
○ The quality of pain management is assessed before
and after the implementation of the intervention by
administering the APS-POK [43] to all eligible cancer
patients in five weekly established sessions. The first
session will be before T0) and thereafter one week
apart: T7-T14-T21-T28. Each session will start at
14.00 on a midweek day. Eligible patients of each
ward were identified by the nurse coordinator in the
morning of the established day of assessment.
○ For all eligible cancer patient demographic and
clinical information were collected. Moreover, date
and time of evaluation, and causes for failed
evaluation were also registered.
End-points
Primary end-point
The primary end-point of the study is the percentage of
hospitalized cancer patients with average severe pain
(score 7-10) within the latest 24 hours in the after sample
as compared to the before sample.
Secondary end-points
Ward level
○ Indicators about opioids administration includes:
type and total amount of opioids administered in
the wards to all patients;
Staff level
○ Knowledge and attitudes of the ward professionals
in pain management were assessed with the Italian
version of the Pain Attitudes and Knowledge Scale
(PAK). The questionnaire was developed and
validated by Lebovitz et al [44], and subsequently
translated, adapted and validated into Italian
[24,42]. The Italian version of the PAK includes
10 items, aiming to evaluate health professionals
relating to their knowledge in the field of pain
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in oncological patients.
Patient level
○ The quality of pain management was assessed
with the APS-POK. The questionnaire was
originally developed and validated with the aim
of assessing pain and pain control as perceived
and rated by the patient [45]. The APS-POK
is constituted of three major sections assessing:
pain intensity and interference during the last
24 hours (9 items from the Pain Inventory),
[46] patient’s satisfaction about pain treatment
(3 items), possible prejudices preventing optimal
pain management (7 items). The APS-POQ was
translated and validated into Italian [43].
Eligibility criteria
Hospital level
1. consent from the Hospital Management to
participate to the study
Ward level
Including criteria
1. consent from the head of the ward to participate
in the study;
2. ward classified as oncology, medicine, respiratory
disease ward according to the regional
classification of hospitals;
3. number of beds;
4. number of ordinary admissions with primary or
secondary diagnosis of tumour (ICD-IX 140-239)
>180 per year;
5. yearly average stay in hospital between 4 and 19
days;
6. punctual prevalence of patients with primary
or secondary diagnosis of tumour
(ICD-IX 140-239) ≥ 8 patients.Excluding criteria
1. the ward had received or is receiving quality
improvement programmes of staff education for
improving pain control.
Staff level
1. affiliation to the ward;
2. informed consent to participate in the study.
Patient level
Including criteria
1. patients admitted in the ward for at least
24 hours;
2. age ≥ 18 years3. able to fill in the questionnaire according the
health care professionals judgment;
4. informed consent to participate to the study.Excluding criteria
1 patient already assessed in one of the previous
assessments.
THE PAC-IFicO programme
In all selected wards the PAC-IFicO programme will
be implemented. The PAC-IFicO programme shows
significant differences if compared to previous Italian
“Pain-free Hospital” experiences. Such differences can
be listed as follows:
➣ a rigorous research in terms of methods and
subsequent phases of the project;
➣ the use within hospital units of a “Program” with the
same modalities of implementation;
➣ comprehensive employment of all the components
of the “Program”;
➣ training based on adult education programs:
education based on local barrier clearing
(pre-education focus) and peer-to-peer training
among colleagues;
➣ local organizational support interventions following
the training phase;
➣ the involvement of both clinicians and nurses into
the project [47];
Additional file 1: Table S1 describes the 4 phases of
the Pac-IFicO Protocol [48,49].
Within each involved units, two Guides (a physician and
a nurse) will be appointed, who will attend a four-day
training course, with the aim to be enabled, in turn, to
train and educate their colleagues in their unit relating to
the “standard implementation” of the Program.
All the patients in the involved units will receive an
information pack on pain control, during the whole
protocol (three months after the completion of the
training course for the health professionals).
After the training course for all the health professionals,
the following organizational support interventions will be
performed:
1. Monthly debate (for three months) on a crucial
clinical case within the unit with the support of
both the appointed Guides and a regional
coordinator;
2. Peer to peer learning interviews among the unit staff
with the Guides
3. Audit interview to the nurse coordinator of the unit
three months after the completion of the training
phase.
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of the quality of the implementation process. In particular,
the following evaluations will be carried out:
➣ Evaluation of the training program; the whole
process of design, implementation and learning
assessment will be evaluated according to the
Quality Improvement Programs. Process indicators
will be used concerning the subsequent phases of
both the training program for the Guides and of the
standard implementation process.
➣ Evaluation of the organizational support program: all
the critical clinical cases discussed within the unit
will be analysed; all the support interviews among
colleagues will be tracked and collected; all the audit
interviews to the nurse coordinator and to the unit
chief will be also analysed.
Ethical approval
The protocol was approved by the Ethics Committee of
the Promoting Center, (CE 11/11, 18 febbraio 2011), and
from the Ethics committees of all participating centres.
Statistical considerations
Primary end-point
The primary outcome measurement in the present study
is the percentage of hospitalized cancer patients with
severe pain within the latest 24 hours (score 7-10).
Sample size
To address the effectiveness of the Pac-Ifico Programme, a
clustered sample size was estimated with an alpha error of
0.05 and a power of 80%, assuming an intraclass correlation
coefficient (ICC) for the primary endpoint equal to 0.01.
According to these assumptions we estimated that 10 hos-
pital wards, with cluster size equal to 25 pre-intervention
and 25 post-intervention patients corresponding to overall
500 patients, would be sufficient to detect an absolute
decrease in the primary endpoint from 20% to 9%,
corresponding to an odds ratio of 0.4.
Statistical analysis
Patients’ characteristics by pre and post-intervention
groups and/or by centres were reported as means,
frequency and percentage, for continuous and categorical
variables, respectively. Student t-test for continuous
variables and Pearson chi-square for categorical variables
were used to compare pre-intervention vs. post-intervention
group.
To account for the nested nature of the study design
(i.e. patients clustered within wards), primary and
secondary endpoints were analysed with a generalized
hierarchical linear model [50,51].Results comparing pre-intervention vs. post-intervention
group were expressed in terms of mean differences and
odds ratios (OR) along with their 95% confidence intervals
(95% CI) for hierarchical linear and logistic models, respect-
ively. Some analyses were adjusted for known confounders
as reported in details in the specific tables.
Two-sided P-values < 0.05 were considered statistically
significant. All the analyses were performed using the
SAS Statistical Package Release 9.1 (SAS Institute, Cary,
NC, USA).
Discussion
Although pain evaluation and management is codified
both in available guidelines and, in Italy, also in the Law
38/2010, pain is still often uncontrolled both in cancer
patients and in patients with non oncological chronic
diseases.
Our Study aims to improve the quality of pain manage-
ment in patients admitted to medicine, oncology and
pneumology units in three Italian Regions: Liguria,
Piemonte and Veneto.
By means of consolidated educational and organizational
methodologies, the Pac-IFicO Programme actually reinforces
current strategies for cancer related pain control according
to international guidelines in some medicine, oncology and
respiratory disease wards. Not only does the present study
aim to consolidate scientific knowledge relating to clinical
and non clinical recommendations contained in the object
Program, but it also aims to assess the effectiveness of the
whole Program as a tool to improve health care in cancer
patients in pain.
The aim of this study was to assess whether the imple-
mentation of the programme may determine effective
changes in the attitudes and behaviour of health profes-
sionals in view of a better practice, and whether these
changes have a positive impact on the control of pain in
cancer patients. The results will be analysed and interpreted
at three levels: the ward level, the staff level, and the patient
level, the last to evaluate the effectiveness of the induced
changes in terms of an improved quality of health care.
One of the most innovative features of the present
programme is the appointment of two Guides in the unit
(a physician and a nurse, i.e. a small team) who will first
attend a 4-day long training course, after which they will
reproduce a “standard implementation” training to all their
colleagues, including all the physicians and nurses within
the involved unit. The hospital staff will thus become
a source of continuous training, which multiplies by
involving new professionals. Moreover, the monthly
grand rounds on critical clinical cases, along with the
peer to peer learning assessment interviews among the
unit health professionals with the Guides strengthen and
improve any educational initiative by including the whole
involved staff.
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